Deep infiltrating endometriosis ms obg short notes

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources

Deep Infiltrating Endometriosis (DIE) — Short Notes (MS OBG)

Definition

Endometriosis = presence of endometrial glands and stroma outside the uterine cavity. It is classified into 3 types:
  1. Superficial peritoneal endometriosis
  2. Ovarian endometriosis (endometrioma)
  3. Deep infiltrating endometriosis (DIE) — lesions infiltrating >5 mm beneath the peritoneal surface, often forming nodules involving bowel, bladder, ureter, rectovaginal septum and uterosacral ligaments
(Robbins & Kumar Basic Pathology, p. 689; Berek & Novak's Gynecology)

Epidemiology

  • Endometriosis occurs in ~10% of reproductive-age women, up to 50% of infertile women
  • DIE is the most severe phenotype, causing significant distortion of pelvic anatomy with dense adhesions
  • Malignant transformation is rare overall and is confined almost exclusively to DIE (still extremely rare) — Robbins, Cotran & Kumar

Pathogenesis (theories)

  1. Regurgitation (retrograde menstruation) theory — endometrial tissue implants at ectopic sites via retrograde flow through the fallopian tubes
  2. Benign metastasis theory — spread of endometrial tissue via blood/lymphatics to distant sites (lung, brain, bone)
  3. Metaplastic theory — coelomic epithelium (mesothelium) undergoes metaplasia into endometrial-type tissue; mesonephric remnants may also differentiate
  4. Extrauterine stem/progenitor cell theory — bone marrow-derived stem cells differentiate into endometrial tissue
Ectopic implants show increased prostaglandin E2, VEGF, matrix metalloproteinases (released by recruited macrophages), and high aromatase activity leading to local estrogen production from androgens — sustaining a proinflammatory, estrogen-dependent lesion.
- Robbins & Kumar Basic Pathology, p. 689

Common Sites of Deep Infiltration

  • Rectovaginal septum (may present as a stricture, with cyclic pain worst in first 2 days of menses)
  • Uterosacral ligaments (often masked by dense adhesions, cul-de-sac)
  • Pouch of Douglas / cul-de-sac
  • Bladder wall and ureter (can cause silent hydronephrosis)
  • Rectosigmoid colon/bowel wall
  • Retrorectal/pararectal spaces (relevant to sacral hypogastric plexus injury during dissection)
- Bailey & Love's Short Practice of Surgery, 28th ed.; Berek & Novak's Gynecology

Clinical Features

  • Chronic pelvic pain, severe dysmenorrhea, deep dyspareunia (uterosacral/rectovaginal nodules), dyschezia (bowel involvement)
  • Cyclical hematuria/flank pain (ureteric/bladder DIE) — can progress silently to loss of renal function
  • Infertility
  • Reduced quality of life
  • Note: severity of disease correlates poorly with symptom severity/staging (rASRM staging is subjective and correlates poorly with pain/infertility)

Diagnosis

  • Clinical exam: nodularity/tenderness on posterior vaginal fornix, fixed retroverted uterus
  • Transvaginal ultrasound (TVUS): good for detecting DIE and endometriomas; poor sensitivity for superficial peritoneal disease (sensitivity ~65%, specificity ~95% for phenotype detection overall)
  • MRI: better delineation of rectovaginal septum, bowel wall, and ureteric involvement pre-operatively
  • Gold standard: laparoscopy with histologic confirmation — visualization of lesions during laparoscopy is diagnostic; positive histology confirms diagnosis, but negative histology does NOT exclude it
  • Classification systems:
    • rASRM (revised American Society for Reproductive Medicine) staging — subjective, poor correlation with pain/infertility
    • ENZIAN classification — specifically developed to supplement rASRM for describing deep infiltrating endometriosis (compartments: rectovaginal septum, vagina, uterosacral ligaments/rectum/pararectal, bladder/ureter); useful for surgical planning
- Berek & Novak's Gynecology

Management

General principle: Severe/deep endometriosis should be managed in a center with multidisciplinary expertise (advanced laparoscopy, colorectal/urology backup) — Berek & Novak's Key Points.

Medical (pain control, not curative for deep nodules)

  • Combined oral contraceptives, progestins, GnRH agonists/antagonists — all roughly equally effective for pain, differ in side effects/cost
  • Hormonal suppression does NOT improve fertility outcomes and has limited efficacy on established deep fibrotic nodules

Surgical (mainstay for DIE)

  • Laparoscopic excision of deep nodules with adhesiolysis (cul-de-sac, uterosacral ligaments)
  • Bowel resection/shaving for rectosigmoid nodules; ureterolysis or ureteric reimplantation for ureteric involvement
  • Total hysterectomy (with excision of disease) preferred over subtotal, since recurrence has been reported in the cervical stump and rectovaginal septum
  • Risk of injury to hypogastric nerve plexus during deep retroperitoneal dissection — can cause postoperative bladder/bowel/sexual dysfunction
  • Ablation/resection plus adhesiolysis improves fertility more than diagnostic laparoscopy alone in mild disease; role less clear in extensive DIE where fertility-sparing vs radical surgery must be individualized

Fertility

  • Endometriosis Fertility Index (EFI) predicts non-IVF pregnancy rates after surgical treatment

Key Exam Points (quick recall)

  1. DIE = one of 3 histologic types of endometriosis; infiltrates >5mm; involves USL, RVS, bowel, bladder, ureter
  2. Diagnosis = laparoscopy + histology (gold standard); TVUS/MRI for mapping before surgery
  3. ENZIAN score = classification specific to deep infiltrating endometriosis
  4. Malignant transformation is rare but, when it occurs in endometriosis, is mainly associated with DIE
  5. Management is multidisciplinary; medical therapy controls pain but surgery is definitive for deep nodules
  6. Complication risk: hypogastric nerve plexus injury, ureteric/bowel injury during excision
This is a shared conversation. Sign in to Orris to start your own chat.